DiagMetrics, Inc.
DiagMetrics is developing a mask-based, point-of-care COVID-19 testing solution that is simple, accessible, and affordable. Their innovative biosensor technology detects active infections and viral loads through exhaled breath condensate, providing rapid and reliable results without the need for medical personnel or labs. The company aims to make rapid diagnostics accessible to all, including individuals with disabilities, and is currently under development with NIH RADx® funding.
Industries
Nr. of Employees
small (1-50)
DiagMetrics, Inc.
Products
Mask-based breath diagnostic test
A mask-mounted diagnostic test that collects exhaled breath condensate and uses an integrated biosensor to detect viral proteins and estimate viral load, returning results to the user via smartphone or audible output in approximately ten minutes.
Mask-based breath diagnostic test
A mask-mounted diagnostic test that collects exhaled breath condensate and uses an integrated biosensor to detect viral proteins and estimate viral load, returning results to the user via smartphone or audible output in approximately ten minutes.
Services
Support for deploying mask-based diagnostic tests in settings from individual point-of-care sites to high-volume mass testing environments; demonstrations and pilot engagement available via contact.
Support for deploying mask-based diagnostic tests in settings from individual point-of-care sites to high-volume mass testing environments; demonstrations and pilot engagement available via contact.
Expertise Areas
- Breath-based diagnostics
- Point-of-care testing
- Biosensor development
- Exhaled breath condensate analysis
Key Technologies
- Exhaled breath condensate (EBC) collection
- Gallium nitride (GaN) biosensors
- Protein/antigen detection in breath
- Wearable mask-based sampling
News & Updates
Startup DiagMetrics plans to parlay novel sample collection and detection technologies into home-use and point of care tests, and was recently awarded funding.
DiagMetrics has recieved an NIH RADx® award to advance its mask-based diagnostic platform.
This feature article outlines the last developments in the field, notably the novel ways of EBA and EBC collection and the analytical aspects of the collected samples.
Startup DiagMetrics plans to parlay novel sample collection and detection technologies into home-use and point of care tests, and was recently awarded funding.
DiagMetrics has recieved an NIH RADx® award to advance its mask-based diagnostic platform.
This feature article outlines the last developments in the field, notably the novel ways of EBA and EBC collection and the analytical aspects of the collected samples.